See also this year's filing and all EDGAR filings for this company.
PDF Report 0001374690_2023_Larimar_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001374690, Larimar Therapeutics Inc.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 120,739,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 831,000 |
3 | remainder_Assets | 4,835,000 |
4 | LiabilitiesCurrent | 10,705,000 |
5 | LiabilitiesNoncurrent | 4,797,000 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 12,276,000 |
9 | ResearchAndDevelopmentExpense | 24,250,000 |
10 | remainder_Expenses | 0 |
11 | remainder_Revenues | 0 |
12 | remainder_NetIncome | 1,171,000 |
13 | remainder_ComprehensiveNetIncome | -31,000 |
yvar | yval | |
---|---|---|
0 | Assets | 126,405,000 |
1 | Liabilities | 15,502,000 |
2 | Expenses | 36,526,000 |
3 | Revenues | 0 |
4 | StockholdersEquity | 110,903,000 |
5 | NetIncome | -35,355,000 |
6 | ComprehensiveNetIncome | -35,370,500 |
7 | BaseVar | 89,817,500 |
8 | EconomicCapitalRatio | 2.19 |